Dr. Stevenson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Mail Code CA-60
Cleveland, OH 44195Phone+1 216-636-6888
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 1995 - 1998- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1993 - 1995
University of FloridaInternship, Internal Medicine, 1992 - 1993- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1992
Certifications & Licensure
OH State Medical License 2012 - 2026
NJ State Medical License 2005 - 2013
PA State Medical License 1994 - 2012- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Philadelphia Magazine Castle Connolly, 2010-2012
Clinical Trials
- Phase 1/2 Study of BDTX-1535 in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations Start of enrollment: 2022 Mar 31
Roles: Contact
Publications & Presentations
PubMed
- Demographic Disparities in Lung Cancer Mortality and Trends in the United States From 1999 Through 2020: A Population-Based CDC Database Analysis.Alexander J Didier, Logan Roof, James Stevenson
Journal of the National Comprehensive Cancer Network. 2024-06-04 - 6 citationsClinical Outcomes With Pembrolizumab-Based Therapies in Recurrent/Refractory NSCLC After Chemoradiation and Consolidative Durvalumab.Lukas Delasos, Wei Wei, Khaled A Hassan, Nathan A Pennell, Pradnya Patil
Clinical Lung Cancer. 2023-09-01 - 6 citationsA Phase 1 Study of Concurrent Neoadjuvant Pembrolizumab Plus Chemoradiation Followed by Consolidation Pembrolizumab in Patients With Resectable Stage IIIA NSCLC.Christopher A Lemmon, Gregory M M Videtic, Sudish Murthy, Kevin L Stephans, Marc Shapiro
JTO Clinical and Research Reports. 2022-07-01
Press Mentions
Update on PD-1/PD-L1 Inhibitors in Extensive-Stage Small Cell Lung CancerDecember 16th, 2020- November Is Lung Cancer Awareness Month! Here's How Medical Advances Are Lowering DeathsNovember 28th, 2020
- Here’s Why Lung Cancer Death Rates Are Improving in the U.S.September 9th, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
